fludarabine has been researched along with Psoriasis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buckley, C; Hoffbrand, AV; Smith, OP | 1 |
Hayag, MV; Nouri, K; Taylor, JR; Tie, C | 1 |
Akça, S; Karadoğan, I; Undar, L | 1 |
Nagler, A; Or, R; Slavin, S; Varadi, G | 1 |
Bryon, RJ; Chakrabarti, S; Griffiths, MJ; Handa, SK; Milligan, DW | 1 |
5 other study(ies) available for fludarabine and Psoriasis
Article | Year |
---|---|
Fludarabine and psoriasis.
Topics: Aged; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Psoriasis; Vidarabine | 1994 |
Topical treatment of psoriasis with fludarabine.
Topics: Administration, Topical; Antineoplastic Agents; Dermatologic Agents; Humans; Male; Psoriasis; Vidarabine | 1997 |
Resolution of psoriatic skin lesions with fludarabine.
Topics: Antineoplastic Agents; CD4-Positive T-Lymphocytes; Humans; Immunosuppressive Agents; Male; Middle Aged; Psoriasis; Vidarabine | 1999 |
Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis.
Topics: Adult; Antineoplastic Agents; Arthritis, Psoriatic; Autoimmunity; Busulfan; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocytes; Male; Psoriasis; Reverse Transcriptase Polymerase Chain Reaction; Vidarabine | 2000 |
Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclosporine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lenograstim; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Nuclear Family; Psoriasis; Recombinant Proteins; T-Lymphocyte Subsets; Transplantation Chimera; Vidarabine | 2001 |